A Common PD-Risk <i>GBA1</i> Variant Disrupts LIMP2 Interaction, Impairs Glucocerebrosidase Function, and Drives Lysosomal and Mitochondrial Dysfunction

Oliver B. Davis(Denali Therapeutics (United States)), Anastasia G. Henry(Denali Therapeutics (United States))
bioRxiv (Cold Spring Harbor Laboratory)
September 2, 2025
Cited by 0


Related Papers